H.R. 2241, Global Health Innovation Act of 2015, as amended

H.R. 2241

Global Health Innovation Act of 2015, as amended

Rep. Albio Sires

December 18, 2015 (114th Congress, 1st Session)

Staff Contact

Floor Situation

On Friday, December 18, 2015, the House will complete consideration of H.R. 2241, the Global Health Innovation Act of 2015, as amended, under suspension of the rules.  H.R. 2241 was introduced on May 5, 2015 by Rep. Albio Sires (D-NJ) and was referred to the Committee on Foreign Affairs, which ordered the bill reported, as amended, by unanimous consent, on November 5, 2015.

Bill Summary

H.R. 2241 requires the Administrator of the U.S. Agency for International Development (USAID), within 180 days of enactment and annually thereafter for four years, to report to Congress on the development and use of global health innovations in its programs, projects, and activities. The report must include information on how USAID is working independently and with partners, donors and the private sector to develop and bring to scale heath products, and how this work is advancing commitments to counter HIV/AIDS, preventable child and maternal deaths, and the spread of infectious diseases.


USAID “is the lead U.S. Government agency that works to end extreme global poverty and enable resilient, democratic societies to realize their potential.”[1]  The agency works with partners worldwide and supports programs “to end extreme poverty and to promote resilient, democratic societies while advancing our security and prosperity.”[2]

According to the bill’s sponsor, “Each year, millions of people in the developing world die of infectious diseases, malnutrition, and complications of pregnancy and childbirth. The Global Health Innovation Act supports a long-term program to develop much needed health technologies such as safe injection devices, rapid diagnostics for diseases, technologies for safe delivery, and other innovative health solutions.”[3]

[1] https://www.usaid.gov/what-we-do
[2] https://www.usaid.gov/who-we-are/mission-vision-values
[3] See Press Release—“Sires Introduces Legislation to Support Global Health Research and Development,” May 12, 2015.


The Congressional Budget Office (CBO) estimates that implementing H.R. 2241 would cost less than $500,000 over the 2016 to 2020 period; such spending would be subject to the availability of appropriated funds.  Enacting H.R. 2241 would not affect direct spending or revenues; therefore, pay-as-you-go procedures do not apply.

Additional Information

For questions or further information please contact Jerry White with the House Republican Policy Committee by email or at 5-0190.